Elevance Health Class Action Lawsuit
Analysis based on 15 articles · First reported May 14, 2025 · Last updated Jun 01, 2025
The class action lawsuit against Elevance Health could negatively impact its stock price and reputation due to allegations of misleading investors. Investors who purchased Elevance Health stock during the specified period may be entitled to compensation, potentially affecting the company's financial outlook.
Rosen Law Firm has filed a class action lawsuit against Elevance Health on behalf of investors who purchased common stock between April 18, 2024, and October 16, 2024. The lawsuit alleges that Elevance Health made false and misleading statements regarding its Medicaid redetermination process and its financial guidance for 2024. Specifically, the company is accused of failing to disclose that the redeterminations were causing a significant rise in the acuity and utilization of its Medicaid members, which was not adequately reflected in its rate negotiations with states or its financial guidance. Investors allegedly suffered damages when the true details became known. The lead plaintiff deadline for the class action is July 11, 2025.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard